216 related articles for article (PubMed ID: 31352106)
1. Hydrogen sulfide-releasing peptide hydrogel limits the development of intimal hyperplasia in human vein segments.
Longchamp A; Kaur K; Macabrey D; Dubuis C; Corpataux JM; Déglise S; Matson JB; Allagnat F
Acta Biomater; 2019 Oct; 97():374-384. PubMed ID: 31352106
[TBL] [Abstract][Full Text] [Related]
2. Hydrogen Sulphide Release via the Angiotensin Converting Enzyme Inhibitor Zofenopril Prevents Intimal Hyperplasia in Human Vein Segments and in a Mouse Model of Carotid Artery Stenosis.
Macabrey D; Deslarzes-Dubuis C; Longchamp A; Lambelet M; Ozaki CK; Corpataux JM; Allagnat F; Déglise S
Eur J Vasc Endovasc Surg; 2022 Feb; 63(2):336-346. PubMed ID: 34916111
[TBL] [Abstract][Full Text] [Related]
3. Sodium thiosulfate acts as a hydrogen sulfide mimetic to prevent intimal hyperplasia via inhibition of tubulin polymerisation.
Macabrey D; Longchamp A; MacArthur MR; Lambelet M; Urfer S; Deglise S; Allagnat F
EBioMedicine; 2022 Apr; 78():103954. PubMed ID: 35334307
[TBL] [Abstract][Full Text] [Related]
4. Clinical Use of Hydrogen Sulfide to Protect Against Intimal Hyperplasia.
Macabrey D; Longchamp A; Déglise S; Allagnat F
Front Cardiovasc Med; 2022; 9():876639. PubMed ID: 35479275
[TBL] [Abstract][Full Text] [Related]
5. Perivascular sustained release of atorvastatin from a hydrogel-microparticle delivery system decreases intimal hyperplasia.
Mylonaki I; Strano F; Deglise S; Allémann E; Alonso F; Corpataux JM; Dubuis C; Haefliger JA; Jordan O; Saucy F; Delie F
J Control Release; 2016 Jun; 232():93-102. PubMed ID: 27091698
[TBL] [Abstract][Full Text] [Related]
6. Recombinant soluble apyrase APT102 inhibits thrombosis and intimal hyperplasia in vein grafts without adversely affecting hemostasis or re-endothelialization.
Ji Y; Adeola O; Strawn TL; Jeong SS; Chen R; Fay WP
J Thromb Haemost; 2017 Apr; 15(4):814-825. PubMed ID: 28079982
[TBL] [Abstract][Full Text] [Related]
7. Increased connexin43 expression in human saphenous veins in culture is associated with intimal hyperplasia.
Déglise S; Martin D; Probst H; Saucy F; Hayoz D; Waeber G; Nicod P; Ris HB; Corpataux JM; Haefliger JA
J Vasc Surg; 2005 Jun; 41(6):1043-52. PubMed ID: 15944608
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of a hydrogen sulfide donor on balloon injury-induced restenosis via the Nrf2/HIF-1α signaling pathway.
Ling K; Xu A; Chen Y; Chen X; Li Y; Wang W
Int J Mol Med; 2019 Mar; 43(3):1299-1310. PubMed ID: 30747216
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the focal adhesion kinase (p125FAK) in the vascular smooth muscle cells of intimal hyperplasia.
Owens LV; Xu L; Marston WA; Yang X; Farber MA; Iacocca MV; Cance WG; Keagy BA
J Vasc Surg; 2001 Aug; 34(2):344-9. PubMed ID: 11496289
[TBL] [Abstract][Full Text] [Related]
10. Supramolecular Tuning of H
Qian Y; Kaur K; Foster JC; Matson JB
Biomacromolecules; 2019 Feb; 20(2):1077-1086. PubMed ID: 30676716
[TBL] [Abstract][Full Text] [Related]
11. Intraluminal Delivery of Simvastatin Attenuates Intimal Hyperplasia After Arterial Injury.
Helkin A; Bruch D; Wilson DR; Gruessner AC; Bader RR; Maier KG; Gahtan V
Vasc Endovascular Surg; 2019 Jul; 53(5):379-386. PubMed ID: 30982448
[TBL] [Abstract][Full Text] [Related]
12. Cystathionine Gamma Lyase Is Regulated by Flow and Controls Smooth Muscle Migration in Human Saphenous Vein.
Zhao S; Deslarzes-Dubuis C; Urfer S; Lambelet M; Déglise S; Allagnat F
Antioxidants (Basel); 2023 Sep; 12(9):. PubMed ID: 37760034
[TBL] [Abstract][Full Text] [Related]
13. Conductive Hydrogen Sulfide-Releasing Hydrogel Encapsulating ADSCs for Myocardial Infarction Treatment.
Liang W; Chen J; Li L; Li M; Wei X; Tan B; Shang Y; Fan G; Wang W; Liu W
ACS Appl Mater Interfaces; 2019 Apr; 11(16):14619-14629. PubMed ID: 30939870
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Mitogen Activated Protein Kinase Activated Protein Kinase II with MMI-0100 reduces intimal hyperplasia ex vivo and in vivo.
Muto A; Panitch A; Kim N; Park K; Komalavilas P; Brophy CM; Dardik A
Vascul Pharmacol; 2012; 56(1-2):47-55. PubMed ID: 22024359
[TBL] [Abstract][Full Text] [Related]
15. Comparative assessment of intimal hyperplasia development after 14 days in two different experimental settings: tissue culture versus ex vivo continuous perfusion of human saphenous vein.
Rey J; Probst H; Mazzolai L; Bosman FT; Pusztaszeri M; Stergiopulos N; Ris HB; Hayoz D; Saucy F; Corpataux JM
J Surg Res; 2004 Sep; 121(1):42-9. PubMed ID: 15313374
[TBL] [Abstract][Full Text] [Related]
16. MK2 inhibitory peptide delivered in nanopolyplexes prevents vascular graft intimal hyperplasia.
Evans BC; Hocking KM; Osgood MJ; Voskresensky I; Dmowska J; Kilchrist KV; Brophy CM; Duvall CL
Sci Transl Med; 2015 Jun; 7(291):291ra95. PubMed ID: 26062847
[TBL] [Abstract][Full Text] [Related]
17. The Benefits of Macromolecular/Supramolecular Approaches in Hydrogen Sulfide Delivery: A Review of Polymeric and Self-Assembled Hydrogen Sulfide Donors.
Kaur K; Carrazzone RJ; Matson JB
Antioxid Redox Signal; 2020 Jan; 32(2):79-95. PubMed ID: 31691577
[No Abstract] [Full Text] [Related]
18. Transduction of peptide analogs of the small heat shock-related protein HSP20 inhibits intimal hyperplasia.
Tessier DJ; Komalavilas P; Liu B; Kent CK; Thresher JS; Dreiza CM; Panitch A; Joshi L; Furnish E; Stone W; Fowl R; Brophy CM
J Vasc Surg; 2004 Jul; 40(1):106-14. PubMed ID: 15218470
[TBL] [Abstract][Full Text] [Related]
19. Arterial levels of oxygen stimulate intimal hyperplasia in human saphenous veins via a ROS-dependent mechanism.
Joddar B; Firstenberg MS; Reen RK; Varadharaj S; Khan M; Childers RC; Zweier JL; Gooch KJ
PLoS One; 2015; 10(3):e0120301. PubMed ID: 25799140
[TBL] [Abstract][Full Text] [Related]
20. Antisense to transforming growth factor-beta1 messenger RNA reduces vein graft intimal hyperplasia and monocyte chemotactic protein 1.
Wolff RA; Ryomoto M; Stark VE; Malinowski R; Tomas JJ; Stinauer MA; Hullett DA; Hoch JR
J Vasc Surg; 2005 Mar; 41(3):498-508. PubMed ID: 15838486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
